NEUROGEN CORP
SC 13D/A, 1997-05-05
PHARMACEUTICAL PREPARATIONS
Previous: NEW FRONTIER MEDIA INC/CO, S-8, 1997-05-05
Next: WOOLWORTH CORPORATION, DEF 14A, 1997-05-05



<PAGE>
 
                      SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, DC  20549

                               -----------------

                                 SCHEDULE 13D
                                (Rule 13d-101)

                   UNDER THE SECURITIES EXCHANGE ACT OF 1934
                             (Amendment No. 1)/1/



                             Neurogen Corporation
                             --------------------
                               (Name of Issuer)

                                 Common Stock
                                 ------------
                        (Title of Class of Securities)

                                  64124 E 106
                                  -----------
                                (CUSIP Number)

                                  Hope Flack
                               BVF Partners L.P.
                       333 West Wacker Drive, Suite 1600
                           Chicago, Illinois  60606
                                (312) 263-7777
                 --------------------------------------------
                 (Name, Address and Telephone Number of Person
               Authorized to Receive Notices and Communications)

                                April 16, 1997
                                --------------
            (Date of Event which Requires Filing of this Statement)

     If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].

          Note: Six copies of this statement, including all exhibits, should be
     filed with the Commission.  See Rule 13d-1(a) for other parties to whom
     copies are to be sent.

                        (Continued on following pages)

                              (Page 1 of 7 Pages)

- -------------------------

/1/    The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
                                        
       The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
 
- -----------------------                                  ---------------------
  CUSIP NO. 64124 E 106                 13D                PAGE 2 OF 7 PAGES
- -----------------------                                  ---------------------
 
- ------------------------------------------------------------------------------
      NAME OF REPORTING PERSON
 1    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      Biotechnology Value Fund, L.P.

- ------------------------------------------------------------------------------
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 2                                                              (a) [X]
                                                                (b) [_]
                                                 
- ------------------------------------------------------------------------------
      SEC USE ONLY
 3
 

- ------------------------------------------------------------------------------
      SOURCE OF FUNDS*
 4    
      WC             

- ------------------------------------------------------------------------------
      CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS
 5    REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)                       [ ]
                      
- ------------------------------------------------------------------------------
      CITIZENSHIP OR PLACE OF ORGANIZATION                 
 6                                                                       
      Delaware        
- ------------------------------------------------------------------------------
                          SOLE VOTING POWER
                     7   
     NUMBER OF            -0-          
 
      SHARES       -----------------------------------------------------------
                          SHARED VOTING POWER
   BENEFICIALLY      8
                          566,920
     OWNED BY
                   -----------------------------------------------------------
       EACH               SOLE DISPOSITIVE POWER
                     9    
    REPORTING             -0-            
 
      PERSON       -----------------------------------------------------------
                          SHARED DISPOSITIVE POWER
       WITH          10
                          566,920
- ------------------------------------------------------------------------------
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 11 
      566,920                  

- ------------------------------------------------------------------------------
      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12                  
                                                                    [ ]
                                              
- ------------------------------------------------------------------------------
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
13    
      4.0%              

- ------------------------------------------------------------------------------
      TYPE OF REPORTING PERSON*
12
      PN          

- ------------------------------------------------------------------------------

                     *SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
 
- -----------------------                                  ---------------------
  CUSIP NO. 64124 E 106                 13D                PAGE 3 OF 7 PAGES
- -----------------------                                  ---------------------
 
- ------------------------------------------------------------------------------
      NAME OF REPORTING PERSON
 1    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      BVF Partners L.P.             

- ------------------------------------------------------------------------------
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 2                                                              (a) [X]
                                                                (b) [_]
                                                 
- ------------------------------------------------------------------------------
      SEC USE ONLY
 3
 

- ------------------------------------------------------------------------------
      SOURCE OF FUNDS*
 4    
      OO

- ------------------------------------------------------------------------------
      CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS
 5    REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)                       [ ]
                      
- ------------------------------------------------------------------------------
      CITIZENSHIP OR PLACE OF ORGANIZATION                 
 6                                                                       
      Delaware        
- ------------------------------------------------------------------------------
                          SOLE VOTING POWER
                     7   
     NUMBER OF            -0-          
 
      SHARES       -----------------------------------------------------------
                          SHARED VOTING POWER
   BENEFICIALLY      8
                          1,055,106
     OWNED BY
                   -----------------------------------------------------------
       EACH               SOLE DISPOSITIVE POWER
                     9    
    REPORTING             -0-            
 
      PERSON       -----------------------------------------------------------
                          SHARED DISPOSITIVE POWER
       WITH          10
                          1,055,106
- ------------------------------------------------------------------------------
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 11 
      1,055,106                

- ------------------------------------------------------------------------------
      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12                  
                                                                    [ ]
                                              
- ------------------------------------------------------------------------------
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
13    
      7.4%              

- ------------------------------------------------------------------------------
      TYPE OF REPORTING PERSON*
12
      PN          

- ------------------------------------------------------------------------------

                     *SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
 
- -----------------------                                  ---------------------
  CUSIP NO. 64124 E 106                 13D                PAGE 4 OF 7 PAGES
- -----------------------                                  ---------------------
 
- ------------------------------------------------------------------------------
      NAME OF REPORTING PERSON
 1    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

      BVF Inc.                       

- ------------------------------------------------------------------------------
      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
 2                                                              (a) [X]
                                                                (b) [_]
                                                 
- ------------------------------------------------------------------------------
      SEC USE ONLY
 3
 

- ------------------------------------------------------------------------------
      SOURCE OF FUNDS*
 4    
      WC, OO

- ------------------------------------------------------------------------------
      CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS
 5    REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)                       [ ]
                      
- ------------------------------------------------------------------------------
      CITIZENSHIP OR PLACE OF ORGANIZATION                 
 6                                                                       
      Delaware        
- ------------------------------------------------------------------------------
                          SOLE VOTING POWER
                     7   
     NUMBER OF            -0-          
 
      SHARES       -----------------------------------------------------------
                          SHARED VOTING POWER
   BENEFICIALLY      8
                          1,055,106
     OWNED BY
                   -----------------------------------------------------------
       EACH               SOLE DISPOSITIVE POWER
                     9    
    REPORTING             -0-            
 
      PERSON       -----------------------------------------------------------
                          SHARED DISPOSITIVE POWER
       WITH          10
                          1,055,106
- ------------------------------------------------------------------------------
      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 11 
      1,055,106                

- ------------------------------------------------------------------------------
      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
12                  
                                                                    [ ]
                                              
- ------------------------------------------------------------------------------
      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
13    
      7.4%              

- ------------------------------------------------------------------------------
      TYPE OF REPORTING PERSON*
12
      IA,CO       

- ------------------------------------------------------------------------------

                     *SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
 
- -----------------------                                  ---------------------
  CUSIP NO. 64124 E 106                 13D                PAGE 5 OF 7 PAGES
- -----------------------                                  ---------------------


     This Amendment No. 1 (this "Amendment") relates to the Statement on
Schedule 13D (the "Statement") dated March 18, 1997, filed with the Securities
and Exchange Commission on behalf of Biotechnology Value Fund, L.P., a Delaware
limited partnership ("BVF"), BVF Partners L.P., a Delaware limited partnership
("Partners"), and BVF Inc., a Delaware corporation ("BVF Inc." and, together
with BVF and Partners, the "Reporting Persons") with respect to the Common
Stock, par value $.025 per share (the "Stock"), of Neurogen Corporation
("Neurogen").

     Item 3 is hereby amended to read in its entirety as follows:

ITEM 3:   SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

     Since March 5, 1997, Partners, in its capacity as general partner of BVF,
has purchased on behalf of such limited partnership an aggregate number of
125,300 shares of the Stock for an aggregate consideration of $2,078,262.50,
utilizing funds provided by BVF from its working capital pursuant to the terms
of its limited partnership agreement with Partners.  In addition, Partners, in
its capacity as investment manager with respect to certain managed accounts, has
purchased on behalf of such managed accounts an aggregate number of 98,800
shares of the Stock for an aggregate consideration of $1,535,834.00, utilizing
funds under management by Partners pursuant to an investment management
agreement between Partners and such managed accounts.

     Item 5 is hereby amended to read in its entirety as follows:

ITEM 5.   INTEREST IN SECURITIES OF THE ISSUER.

     (a) BVF beneficially owns 566,920 shares of the Stock, Partners
beneficially owns 1,055,106 shares of the Stock, and BVF Inc. beneficially owns
1,055,106 shares of the Stock, approximately 4.0%, 7.4% and 7.4%, respectively,
of the aggregate number of shares outstanding as of May 2, 1997.

     (b) BVF shares voting and dispositive power over the 566,920 shares of the
Stock it beneficially owns with Partners.  Partners and BVF Inc. share voting
and dispositive power over the 1,055,106 shares of the Stock they beneficially
own with, in addition to BVF, the managed accounts on whose behalf Partners, as
investment manager, purchased such shares.  The managed accounts on whose behalf
Partners owns shares of the Stock are Investment 10 L.L.C., an Illinois limited
liability company ("ILL10"), Palamundo, L.D.C., a limited duration company
organized under the laws of the Cayman Islands ("Palamundo"), ZPG Securities,
L.L.C., a New York limited liability company ("ZPG") and Biotechnology Value
Fund, Ltd., a Cayman Islands Corporation ("BVF Ltd.").   ILL10, Palamundo, ZPG
and BVF Ltd. are collectively referred to herein as the "Accounts."  The
Accounts specialize in holding biotechnology stocks for investment purposes and
the business address of each is c/o BVF Partners L.P., 333 West Wacker 
<PAGE>
 
- -----------------------                                  ---------------------
  CUSIP NO. 64124 E 106                 13D                PAGE 6 OF 7 PAGES
- -----------------------                                  ---------------------

Drive, Suite 1600, Chicago, Illinois 60606.

     (c) Exhibit B attached hereto contains information as to all transactions
in the Stock by the Reporting Persons since the most recent filing on Schedule
13D.  All such transactions were made for cash in open market, over-the-counter
transactions.  No other transactions in the Stock have been effected by the
Reporting Persons since the most recent filing on Schedule 13D.

     (d) The Accounts are entitled to receive dividends and any sale proceeds
with respect to the Stock in proportion to their respective ownership interests
therein.

     Item 7 is hereby amended to read in its entirety as follows:

ITEM 7.   MATERIAL TO BE FILED AS EXHIBITS.

     Exhibit A - Agreement Regarding Joint Filing

     Exhibit B - Transactions in the Stock by the Reporting Persons since the
most recent filing on Schedule 13D.
<PAGE>
 
- -----------------------                                  ---------------------
  CUSIP NO. 64124 E 106                 13D                PAGE 7 OF 7 PAGES
- -----------------------                                  ---------------------

     After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

Dated:  May 2, 1997

        BIOTECHNOLOGY VALUE FUND, L.P.

        By:  BVF Partners L.P., its general partner

             By:  BVF Inc., its general partner

                  By:  /s/ MARK N. LAMPERT
                       -------------------
                       Mark N. Lampert
                       President

        BVF PARTNERS L.P.

        By:  BVF Inc., its general partner

             By:  /s/ MARK N. LAMPERT
                  -------------------
                  Mark N. Lampert
                  President

        BVF INC.

        By:  /s/ MARK N. LAMPERT
             -------------------
             Mark N. Lampert
             President

<PAGE>
 
                                   EXHIBIT A

                       AGREEMENT REGARDING JOINT FILING
                       --------------------------------


     The undersigned, Biotechnology Value Fund, L.P., a Delaware limited
partnership, and BVF Partners L.P., a Delaware limited partnership, and BVF
Inc., a Delaware corporation, hereby agree and acknowledge that the Amendment
containing the information required by Schedule 13D, to which this Agreement is
attached as an exhibit, is filed on behalf of each of them.  The undersigned
further agree that any further amendments or supplements thereto shall also be
filed on behalf of each of them.

Dated:  May 2, 1997

        BIOTECHNOLOGY VALUE FUND, L.P.                   
                                                         
        By:  BVF Partners L.P., its general partner      
                                                         
             By:  BVF Inc., its general partner          
                                                         
                  By:  /s/ MARK N. LAMPERT               
                       -------------------               
                       Mark N. Lampert                   
                       President                         
                                                         
        BVF PARTNERS L.P.                                
                                                         
        By:  BVF Inc., its general partner               
                                                         
             By:  /s/ MARK N. LAMPERT                    
                  -------------------                    
                  Mark N. Lampert                        
                  President                              
                                                         
        BVF INC.                                         
                                                         
        By:  /s/ MARK N. LAMPERT                         
             -------------------                         
             Mark N. Lampert                             
             President                                    

<PAGE>
 
                                   EXHIBIT B

              TRANSACTIONS IN THE STOCK BY THE REPORTING PERSONS
              --------------------------------------------------
                 SINCE THE MOST RECENT FILING ON SCHEDULE 13D
                 --------------------------------------------
<TABLE>
<CAPTION>
- -----------------------------------------------------------------------------
Settlement                For the                Price Per  Type of               
- ----------                -------                ---------  -------               
   Date         By      Account of    Quantity     Share     Trade    Broker      
   ----         --      ----------    --------     -----     -----    ------      
- -----------------------------------------------------------------------------
<S>          <C>           <C>       <C>        <C>         <C>        <C>         
  03/06/97   Partners      BVF         20,000     17.1875   Purchase   GROW        
- -----------------------------------------------------------------------------      
  03/06/97   Partners      ILL10        4,000     17.1875   Purchase   GROW        
- -----------------------------------------------------------------------------      
  03/06/97   Partners      PAL          2,000     17.1875   Purchase   GROW        
- -----------------------------------------------------------------------------      
  03/06/97   Partners      ZPG          2,000     17.1875   Purchase   GROW        
- -----------------------------------------------------------------------------      
  03/06/97   Partners      BVF, Ltd.   12,000     17.1875   Purchase   GROW        
- -----------------------------------------------------------------------------      
  03/10/97   Partners      BVF          2,500     17.2500   Purchase   GROW        
- -----------------------------------------------------------------------------      
  03/11/97   Partners      BVF          8,000     17.2500   Purchase   RSSF        
- -----------------------------------------------------------------------------      
  03/11/97   Partners      PAL          4,000     17.2500   Purchase   RSSF        
- -----------------------------------------------------------------------------      
  03/11/97   Partners      ZPG          3,000     17.2500   Purchase   RSSF        
- -----------------------------------------------------------------------------      
  03/11/97   Partners      BVF         35,000     17.5000   Purchase   GROW        
- -----------------------------------------------------------------------------      
  03/11/97   Partners      BVF, Ltd.   15,000     17.5000   Purchase   GROW        
- -----------------------------------------------------------------------------      
  03/13/97   Partners      BVF         25,000     17.8750   Purchase   GROW        
- -----------------------------------------------------------------------------      
  03/21/97   Partners      ILL10          800     19.0000   Purchase   INET        
- -----------------------------------------------------------------------------      
  04/03/97   Partners      BVF            300     19.0000   Purchase   MIST        
- -----------------------------------------------------------------------------      
  04/16/97   Partners      BVF          4,000     14.3750   Purchase   GROW        
- -----------------------------------------------------------------------------      
  04/16/97   Partners      ILL10        1,000     14.3750   Purchase   GROW        
- -----------------------------------------------------------------------------      
  04/16/97   Partners      PAL          2,000     14.3750   Purchase   GROW        
- -----------------------------------------------------------------------------      
  04/16/97   Partners      ZPG          1,000     14.3750   Purchase   GROW        
- -----------------------------------------------------------------------------      
  04/16/97   Partners      BVF, Ltd.    2,000     14.3750   Purchase   GROW        
- -----------------------------------------------------------------------------      
  04/25/97   Partners      ILL10        3,500     14.1250   Purchase   GROW        
- -----------------------------------------------------------------------------      
  04/25/97   Partners      BVF, Ltd.    4,000     14.1250   Purchase   GROW        
- -----------------------------------------------------------------------------      
  04/28/97   Partners      BVF          3,200     14.1250   Purchase   GROW        
- -----------------------------------------------------------------------------      
  04/28/97   Partners      BVF, Ltd.    1,800     14.1250   Purchase   GROW        
- -----------------------------------------------------------------------------      
</TABLE> 
<PAGE>
 
<TABLE> 
<CAPTION> 
- -----------------------------------------------------------------------------     
Settlement                For the                Price Per  Type of               
- ----------                -------                ---------  -------               
   Date         By      Account of    Quantity     Share     Trade    Broker      
   ----         --      ----------    --------     -----     -----    ------      
- -----------------------------------------------------------------------------
<S>          <C>         <C>          <C>         <C>       <C>       <C> 
  04/29/97   Partners      BVF         27,300     14.1250   Purchase   GROW       
- -----------------------------------------------------------------------------     
  04/29/97   Partners      ILL10        4,000     14.1250   Purchase   GROW       
- -----------------------------------------------------------------------------     
  04/29/97   Partners      PAL          2,000     14.1250   Purchase   GROW       
- -----------------------------------------------------------------------------     
  04/29/97   Partners      ZPG          1,800     14.1250   Purchase   GROW       
- -----------------------------------------------------------------------------     
  04/29/97   Partners      BVF, Ltd.   14,900     14.1250   Purchase   GROW       
- -----------------------------------------------------------------------------     
  04/30/97   Partners      PAL          2,500     14.1250   Purchase   GROW       
- -----------------------------------------------------------------------------     
  04/30/97   Partners      ZPG          2,500     14.1250   Purchase   GROW       
- -----------------------------------------------------------------------------     
  05/01/97   Partners      ILL10        1,500     13.9380   Purchase   GROW       
- -----------------------------------------------------------------------------     
  05/01/97   Partners      PAL            800     13.9380   Purchase   GROW       
- -----------------------------------------------------------------------------     
  05/01/97   Partners      ZPG            700     13.9380   Purchase   GROW       
- -----------------------------------------------------------------------------     
  05/01/97   Partners      BVF, Ltd.    5,000     13.9380   Purchase   GROW       
- -----------------------------------------------------------------------------     
  05/05/97   Partners      ILL10        1,000      14.625   Purchase   GROW       
- -----------------------------------------------------------------------------     
  05/05/97   Partners      ZPG          1,000      14.625   Purchase   GROW       
- -----------------------------------------------------------------------------     
  05/05/97   Partners      BVF, Ltd.    3,000      14.625   Purchase   GROW       
- -----------------------------------------------------------------------------     
</TABLE> 
 
INET         =             Instinet
GROW         =             Pacific Growth Inc.
MIST         =             Mr. Stock Inc.
RSSF         =             Robertson Stephens & Co.
 
 


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission